PLACENTAL GROWTH FACTOR, SOLUBLE FLT1 AND ENDOGLIN ARE PREDICTORS OF THE ANGIOGENIC STATUS OF A SUBJECT

摘要

The present invention relates to diagnostic means and methods. Specifically, the present invention relates to a method for diagnosing the angiogenic status of a subject suffering from coronary heart disease. Further, it relates to a method of diagnosing whether a subject suffering from coronary heart disease is susceptible for a pro-angiogenic therapy. Finally, the present invention encompasses diagnostic devices and kits for carrying out the aforementioned methods.